High Outlier

Strength

137; 50 ug/1; ug/1

NDC

00037024523

Classification

Brand

Dosage Form

SPRAY, METERED

Route

NASAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA202236

On Market Since

10/1/2016

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.1%

3Y

+5.0%

5Y

+9.6%

All

+56.6%